JANX Operating Cash Flow (Statement)
Janux Therapeutics Inc · Operating Cash Flow (Statement)
JANX Operating Cash Flow (Statement)
Latest reported-$41.25Mperiod ending
JANX TTM Cash from Operations (-$4.37M → -$41.25M)
TTM operating cash flow (statement)
High-resolution chart · PNG
JANX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -41,251,000 | |
| -77,548,000 | |
| -82,235,000 | |
| -70,418,000 | |
| -59,793,000 | |
| -46,001,000 | |
| -43,814,000 | |
| -36,990,000 | |
| -46,468,000 | |
| -51,501,000 | |
| -50,575,000 | |
| -52,587,000 | |
| -54,292,000 | |
| -45,311,000 | |
| -42,922,000 | |
| -41,490,000 | |
| -33,930,000 | |
| -34,061,000 | |
| -16,976,000 | |
| -8,124,000 | |
| -3,353,000 | |
| 2,070,000 | |
| -4,369,000 |